Immune-complex membranoproliferative glomerulonephritis

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Complement inhibitor (C3) 1 substance
Phase IV: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase IV

1 trial
  • Swedish Orphan Biovitrum AB (publ) Commercial
    PEGCETACOPLAN
    2025-524487-37-00 4 countries n=69 Orphan
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Swedish Orphan Biovitrum AB (publ) Commercial 1 Phase IV 0
← All indication landscapes